Zhejiang Shapuaisi Pharmaceutical Co Ltd (603168) — Cash Flow Reinvestment Rate
Zhejiang Shapuaisi Pharmaceutical Co Ltd (603168) has a Cash Flow Reinvestment Rate of 4.07x as of September 2025, reinvesting CN¥34.84 Million (capex CN¥34.84 Million ) from operating cash flow of CN¥8.57 Million. Explore Zhejiang Shapuaisi Pharmaceutical Co Ltd capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Zhejiang Shapuaisi Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2008–2024)
Historical reinvestment intensity for Zhejiang Shapuaisi Pharmaceutical Co Ltd across 17 annual periods. Also explore how large is Zhejiang Shapuaisi Pharmaceutical Co Ltd's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Zhejiang Shapuaisi Pharmaceutical Co Ltd (2008–2024)
Year-by-year capital reinvestment analysis for Zhejiang Shapuaisi Pharmaceutical Co Ltd. For live market cap and broader valuation context, see Zhejiang Shapuaisi Pharmaceutical Co Ltd market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 7.90x | CN¥202.80 Million | CN¥25.67 Million | CN¥128.11 Million | ▲ +4.2% |
| 2023 | 7.58x | CN¥314.65 Million | CN¥41.49 Million | CN¥219.80 Million | ▲ +354.4% |
| 2022 | 1.67x | CN¥193.13 Million | CN¥115.72 Million | CN¥148.69 Million | ▼ -62.5% |
| 2021 | 4.45x | CN¥448.68 Million | CN¥100.78 Million | CN¥153.44 Million | ▲ +46.6% |
| 2020 | 3.04x | CN¥133.91 Million | CN¥44.09 Million | CN¥17.18 Million | ▲ +566.2% |
| 2019 | 0.46x | CN¥27.11 Million | CN¥59.47 Million | CN¥20.33 Million | ▼ -87.4% |
| 2018 | 3.62x | CN¥363.80 Million | CN¥100.37 Million | CN¥58.38 Million | ▼ -15.1% |
| 2017 | 4.27x | CN¥194.50 Million | CN¥45.57 Million | CN¥114.00 Million | ▲ +281.3% |
| 2016 | 1.12x | CN¥329.44 Million | CN¥294.33 Million | CN¥39.94 Million | ▼ -28.1% |
| 2015 | 1.56x | CN¥177.94 Million | CN¥114.27 Million | CN¥97.94 Million | ▲ +124.8% |
| 2014 | 0.69x | CN¥102.53 Million | CN¥147.99 Million | CN¥102.53 Million | ▲ +13.8% |
| 2013 | 0.61x | CN¥71.73 Million | CN¥117.86 Million | CN¥71.73 Million | ▼ -43.1% |
| 2012 | 1.07x | CN¥71.91 Million | CN¥67.27 Million | CN¥71.91 Million | ▼ -45.3% |
| 2011 | 1.95x | CN¥29.59 Million | CN¥15.14 Million | CN¥29.59 Million | ▲ +326.0% |
| 2010 | 0.46x | CN¥8.06 Million | CN¥17.57 Million | CN¥8.06 Million | ▲ +56.1% |
| 2009 | 0.29x | CN¥8.49 Million | CN¥28.87 Million | CN¥8.49 Million | ▼ -74.7% |
| 2008 | 1.16x | CN¥13.01 Million | CN¥11.20 Million | CN¥13.01 Million | — |